Celltrion
068270.KS
#825
Rank
A$41.64 B
Marketcap
A$190.38
Share price
-0.89%
Change (1 day)
15.16%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): A$2.88

According to Celltrion 's latest financial reports the company's current EPS (TTM) is A$2.67. an increase over its 2024 EPS that were of A$1.74.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025A$4.58163.66%
2024A$1.74-53.73%
2023A$3.76-2.08%
2022A$3.84-11.72%
2021A$4.352.03%
2020A$4.2682.8%
2019A$2.3318.31%
2018A$1.97-36.33%
2017A$3.09161.25%
2016A$1.182.86%
2015A$1.1517.84%
2014A$0.985.87%
2013A$0.92-70.85%
2012A$3.17134.09%
2011A$1.3543.59%
2010A$0.9474.49%
2009A$0.54317.8%
2008A$0.13-71.7%
2007A$0.46